ATH-1020
- Generic Name
- ATH-1020
Safety, Tolerability, and Pharmacokinetics Study of ATH-1020
- First Posted Date
- 2021-12-27
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- Athira Pharma
- Target Recruit Count
- 32
- Registration Number
- NCT05169671
- Locations
- 🇺🇸
Biotrial, Inc., Newark, New Jersey, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath